Yale researchers create “humanized” liver in living mice to study chronic liver diseases

Yale researchers have created a functional “humanized” liver in living mice that will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases afflicting tens of millions of people in the United States.

SCHOTT Pharma reports good start into fiscal year 2024 – Biotech Investments

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results SCHOTT Pharma reports good start into fiscal year 2024 29.02.2024

March 1, 2024

Safe Supply Streaming Co. Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange

Toronto, Ontario–(Newsfile Corp. – September 22, 2023) – Safe Supply Streaming Co. Ltd. (formerly Origin Therapeutics Inc.) (“Safe Supply” or the “Company“) is pleased to announce

September 22, 2023

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA | Psychedelic Invest

Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that based on positive

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.